Availability of Interventional Oncology in Germany in the Years 2018 and 2019 - Results from a Nationwide Database (DeGIR Registry Data).

IF 1.7
Christoph Georg Radosa, Jonathan Nadjiri, Andreas H Mahnken, Arno Bücker, Lothar J Heuser, Dominik Morhard, Peter Landwehr, Ansgar Berlis, Marcus Katoh, Peter Reimer, Balthasar Schachtner, Michael Ingrisch, Philipp Paprottka, Ralf-Thorsten Hoffmann
{"title":"Availability of Interventional Oncology in Germany in the Years 2018 and 2019 - Results from a Nationwide Database (DeGIR Registry Data).","authors":"Christoph Georg Radosa,&nbsp;Jonathan Nadjiri,&nbsp;Andreas H Mahnken,&nbsp;Arno Bücker,&nbsp;Lothar J Heuser,&nbsp;Dominik Morhard,&nbsp;Peter Landwehr,&nbsp;Ansgar Berlis,&nbsp;Marcus Katoh,&nbsp;Peter Reimer,&nbsp;Balthasar Schachtner,&nbsp;Michael Ingrisch,&nbsp;Philipp Paprottka,&nbsp;Ralf-Thorsten Hoffmann","doi":"10.1055/a-1729-0951","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Over the past few decades, radiology has established itself in tumor therapy through interventional oncology including innovative and efficient procedures for minimalinvasive treatment of various tumor entities besides the \"classic\" therapeutic options such as surgery, chemotherapy and radiotherapy.Aim of this study was to evaluate the extent to which interventional oncology can provide nationwide care using the data from the register of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR registry), which records radiological interventions as part of quality assurance.</p><p><strong>Methods: </strong>The numbers of interventions of participating clinics, which were recorded as part of module D (oncological procedures including TACE or other tumor-specific embolization, ablation, percutaneous tumor therapy) and identified by the DeGIR registry between 2018 and 2019, were analyzed retrospectively. The collected intervention data were evaluated regarding federal states and 40 smaller regions (administrative districts and former administrative districts).</p><p><strong>Results: </strong>In 2018, 11 653 oncological interventions in 187 clinics were recorded by the DeGIR registry. In 2019, the number of participating clinics rose to 216 and the number of oncological interventions increased by 6 % to 12 323. The average number of oncological interventions per clinic decreased slightly from 62.5 (2018) to 57.1 (2019). The DeGIR requirement for being certified as a training center was met by 116 clinics in 2018 including 31 clinics with more than 100 interventions and 129 clinics in 2019 including 36 with more than 100 interventions. Oncological interventions have been performed in each of the 40 regions. An average of 599 interventions per region (standard deviation of 414) was recorded in the period between 2018 and 2019.</p><p><strong>Conclusion: </strong>Based on the distribution of the documented oncological interventions at federal state level as well as the district level, the supply of interventional tumor therapy depends on the geographical location. Therefore, the demand of oncological interventions might not be sufficiently covered in some regions.</p><p><strong>Key points: </strong>· Interventional-oncological tumor therapies are performed throughout Germany. · Looking at the notable geographical differences, the need for interventional oncological procedures does not seem to be sufficiently met.. · In order to improve the comprehensive provision of oncological interventions, the training of interventional radiologists should be promoted further..</p><p><strong>Citation format: </strong>· Radosa CG, Nadjiri J, Mahnken AH et al. Availability of Interventional Oncology in Germany in the Years 2018 and 2019 - Results from a Nationwide Database (DeGIR Registry Data). Fortschr Röntgenstr 2022; 194: 755 - 761.</p>","PeriodicalId":520772,"journal":{"name":"RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin","volume":" ","pages":"755-761"},"PeriodicalIF":1.7000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-1729-0951","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/2/24 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Objective: Over the past few decades, radiology has established itself in tumor therapy through interventional oncology including innovative and efficient procedures for minimalinvasive treatment of various tumor entities besides the "classic" therapeutic options such as surgery, chemotherapy and radiotherapy.Aim of this study was to evaluate the extent to which interventional oncology can provide nationwide care using the data from the register of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR registry), which records radiological interventions as part of quality assurance.

Methods: The numbers of interventions of participating clinics, which were recorded as part of module D (oncological procedures including TACE or other tumor-specific embolization, ablation, percutaneous tumor therapy) and identified by the DeGIR registry between 2018 and 2019, were analyzed retrospectively. The collected intervention data were evaluated regarding federal states and 40 smaller regions (administrative districts and former administrative districts).

Results: In 2018, 11 653 oncological interventions in 187 clinics were recorded by the DeGIR registry. In 2019, the number of participating clinics rose to 216 and the number of oncological interventions increased by 6 % to 12 323. The average number of oncological interventions per clinic decreased slightly from 62.5 (2018) to 57.1 (2019). The DeGIR requirement for being certified as a training center was met by 116 clinics in 2018 including 31 clinics with more than 100 interventions and 129 clinics in 2019 including 36 with more than 100 interventions. Oncological interventions have been performed in each of the 40 regions. An average of 599 interventions per region (standard deviation of 414) was recorded in the period between 2018 and 2019.

Conclusion: Based on the distribution of the documented oncological interventions at federal state level as well as the district level, the supply of interventional tumor therapy depends on the geographical location. Therefore, the demand of oncological interventions might not be sufficiently covered in some regions.

Key points: · Interventional-oncological tumor therapies are performed throughout Germany. · Looking at the notable geographical differences, the need for interventional oncological procedures does not seem to be sufficiently met.. · In order to improve the comprehensive provision of oncological interventions, the training of interventional radiologists should be promoted further..

Citation format: · Radosa CG, Nadjiri J, Mahnken AH et al. Availability of Interventional Oncology in Germany in the Years 2018 and 2019 - Results from a Nationwide Database (DeGIR Registry Data). Fortschr Röntgenstr 2022; 194: 755 - 761.

2018年和2019年德国介入肿瘤学的可用性-来自全国数据库的结果(DeGIR注册数据)。
目的:在过去的几十年里,放射学通过介入肿瘤学在肿瘤治疗中建立了自己的地位,除了“经典”的治疗选择,如手术、化疗和放疗外,还包括创新和有效的微创治疗各种肿瘤实体的方法。本研究的目的是利用德国介入放射学和微创治疗学会(DeGIR)注册的数据来评估介入肿瘤学在多大程度上可以提供全国范围的护理,该注册记录了放射治疗作为质量保证的一部分。方法:回顾性分析2018年至2019年期间,作为模块D(肿瘤手术,包括TACE或其他肿瘤特异性栓塞、消融、经皮肿瘤治疗)的一部分记录并由DeGIR登记处确定的参与诊所的干预措施数量。收集到的干预数据在联邦州和40个较小的地区(行政区和前行政区)进行了评估。结果:2018年,DeGIR登记处记录了187家诊所的11653例肿瘤干预。2019年,参与的诊所数量增加到216家,肿瘤干预数量增加了6%,达到12 323家。每家诊所的平均肿瘤干预次数从62.5次(2018年)略有下降至57.1次(2019年)。2018年,116家诊所达到了认证为培训中心的DeGIR要求,其中31家诊所有100多项干预措施,2019年有129家诊所达到了认证要求,其中36家诊所有100多项干预措施。在这40个地区都进行了肿瘤干预。2018年至2019年期间,每个地区平均记录了599项干预措施(标准差为414)。结论:根据联邦州和地区肿瘤介入治疗的分布情况,肿瘤介入治疗的供应取决于地理位置。因此,在一些地区,肿瘤干预的需求可能没有得到充分的覆盖。·介入肿瘤治疗在全德国开展。·从显著的地理差异来看,对介入肿瘤手术的需求似乎没有得到充分满足。·为了提高肿瘤干预的综合提供,应进一步促进介入放射科医师的培训。引文格式:·Radosa CG, Nadjiri J, Mahnken AH等。2018年和2019年德国介入肿瘤学的可用性-来自全国数据库的结果(DeGIR注册数据)。Fortschr Röntgenstr 2022;194: 755 - 761。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书